Professor of Surgery, University Tex Houston
General Surgery
Dr. Kelly K. Hunt, MD
|
|
Give Review
Kelly K. Hunt works in the field of General Surgery. She researched medicine at University of Tennessee College of Medicine. She received 4 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACS)". Kelly Hunt is a published doctor and has 101 publications published. The lastest was: 'Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.' She is registered with Medicare.
Publications
- Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
- Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-Analysis.
- Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
- Chimeric antigen receptor T cells targeting HERV-K inhibit breast Cancer and its metastasis through downregulation of Ras.
- Optimizing Mammography Screening Intervals.
- Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple negative breast Cancer.
- PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
- Reply to L. Antolini et al.
- Spotlight on Neoadjuvant Therapy for Breast Cancer.
- Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast Cancer patients enrolled in ACOSOG Z1071 (Alliance).
- Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Tr...
- Challenging a traditional paradigm: 12-year experience with autologous free flap breast reconstruction for inflammatory breast Cancer.
- Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.
- GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast Cancer by immunohistochemistry.
- Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer.
- Hypofractionated whole Breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breas...
- Accuracy of Preoperative Percutaneous Biopsy for the Diagnosis of Retroperitoneal LipoSarcoma Subtypes.
- Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: Findings From the A...
- Breast Conservation in the Setting of Contemporary Multimodality Treatment Provides Excellent Outcomes for Patients with Occult Primary Breast Cancer.
- The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.
- Neoadjuvant Therapy in the Treatment of Breast Cancer.
- Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer.
- Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in C...
- Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation.
- Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment.
- Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors.
- The Controversy Regarding Margin Width in Breast Cancer: Enough is Enough.
- Too Much, Too Little, or Just Right? Tumor Margins in Women Undergoing Breast-Conserving Surgery.
- Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast Cancer.
- Mesenchymal to epithelial transition in Sarcomas.
- Which threshold for ER positivity? A retrospective study based on 9639 patients.
- Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.
- Incidence and consequence of close margins in patients with ductal Carcinoma-in situ treated with mastectomy: is further therapy warranted?
- Benefit of Adjuvant Brachytherapy Versus External Beam Radiation for Early Breast Cancer: Impact of Patient Stratification on Breast Preservation.
- Image-guided Percutaneous Ablation of Small Breast Cancer: Which Technique is Leading the Pack?
- Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab ...
- Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast Cancer: the ACOSOG Z1071 (Alliance) clinical trial.
- Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy.
- Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients.
- Hbo1 Is a Cyclin E/CDK2 Substrate That Enriches Breast Cancer Stem-like Cells.
- Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy.
- Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast Cancer.
- Comparative Analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer.
- Impact of chemotherapy sequencing on local-regional failure risk in breast Cancer patients undergoing breast-conserving therapy.
- Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast Cancer.
- Elafin, an inhibitor of elastase, is a prognostic indicator in breast Cancer.
- Uterine LeiomyoSarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution's Experience.
- Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival.
- Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy.
- Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population.
- Biology, treatment, and outcome in very young and older women with DCIS.
- Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast Cancer.
- A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast Cancer.
- Comparative Analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States.
- Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine LeiomyoSarcoma.
- The role of surgery in the multidisciplinary management of patients with localized gastroIntestinal stromal tumors.
- American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns.
- Changing Behavior in Clinical Practice in Response to the ACOSOG Z0011 Trial: A Survey of the American Society of Breast Surgeons.
- The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer.
- Biologic features and prognosis of ductal Carcinoma in situ are not adversely impacted by initial large body mass.
- Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast Cancer.
- Imaging features of primary Breast sarcoma.
- LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients.
- Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision.
- Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors.
- Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast Cancer patients with a positive sentinel l...
- Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current...
- Positive Sentinel Nodes Without Axillary Dissection: Implications for the Radiation Oncologist.
- Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer.
- Triple-negative breast Cancer is not a contraindication for breast conservation.
- Breast conservation therapy in the 21st century.
- Local-Regional Recurrence With and Without Radiation Therapy after Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3n0 Breast Cancer.
- Occult axillary lymph node metastasis do not have prognostic significance in early stage breast Cancer.
- Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy.
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast Cancer.
- Tamoxifen Downregulates Ets-oncogene Family Members ETV4 and ETV5 in Benign Breast Tissue: Implications for Durable Risk Reduction.
- Age and Associated Fibrocystic Changes are Prognostically Significant in Patients with Small Node-Negative (T1a,bN0) Invasive Breast Cancer.
- Response to the Letter to the Editor: Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOS...
- Incorporation of Adjuvant Therapy into the Multimodality Management of GastroIntestinal Stromal Tumors of the Stomach in the United States.
- Targeting low molecular weight cyclin E (LMW-E) in breast Cancer.
- Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast Cancer: impac...
- Management of local-regional recurrence following immediate breast reconstruction in patients with early breast Cancer treated without postmastectomy radiotherapy.
- Follicular dendritic cell Sarcoma and associated myasthenia gravis: true,true, related?
- Accelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast Cancer in the setting of breast...
- Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-posi...
- Delays in Primary Surgical Treatment Are Not Associated with Significant Tumor Size Progression in Breast Cancer Patients.
- Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
- Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death.
- Impact of progression during neoadjuvant chemotherapy on surgical management of breast Cancer.
- Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
- Classification of ipsilateral Breast tumor recurrences after Breast conservation therapy can predict patient prognosis and facilitate treatment planning.
- Have we made progress in inflammatory breast Cancer? Not so fast.
- Prognostic significance of tumor grading and staging in mammary Carcinomas with neuroendocrine differentiation.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- Axillary dissection vs no axillary dissection in women with invasive breast Cancer and sentinel node metastasis: a randomized clinical trial.
- A Multidisciplinary Protocol for Planned Skin-Preserving Delayed Breast Reconstruction for Patients with Locally Advanced Breast Cancer Requiring Postmastectomy Radiat...
- Isolated limb perfusion for unresectable extremity Sarcoma: Results of 2 single-institution phase 2 trials.
- Integrative genomic characterization and a genomic staging system for gastroIntestinal stromal tumors.
- Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the Breast.
- Disseminated tumor cells in biologic subtypes of stage I-III breast Cancer patients.
Schools
UNIV OF TN HLTH SCI CTR
University Of California Los Angeles
MD Anderson Cancer Center
Procedures Preformed
- Adrenalectomy
- Appendectomy, Open
- Biopsy of Breast
- Breast Reconstruction
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Anal Fissure
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
UCLA Medical Center -
University of Tennessee College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1023114808 | |
| NPPES Provider LastName | HUNT | |
| NPPES Provider FirstName | KELLY | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023114808 |
| Last Name Of The Provider | HUNT |
| First Name Of The Provider | KELLY |
| View All |
Similar Doctors
|
|
Dr. Michael F. Appel, MD |
|
|
Dr. Kuojen Tsao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Anaya, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Uriel Mushin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Serene Shereef, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vergel V. Cruz, MD |
|
|
Dr. Lee R. Hafen, MD |
|
|
Dr. Peter A. Walker, MD |